Because CaMKII activation was reported to inhibit HCC metastasis [28,29], CaMKII phosphorylation levels were analyzed in cells in which HBV was undergoing replication (Figure 1). The gene discussed is CAMK2G; the disease is hepatocellular carcinoma.